US 9487526
Quinoxaline derivatives as GPR6 modulators
granted A61KA61K31/197A61K31/498
Quick answer
US patent 9487526 (Quinoxaline derivatives as GPR6 modulators) held by Takeda Pharmaceutical Company Limited expires Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Nov 08 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 03 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K31/197, A61K31/498, A61K31/4985, A61K31/5025